Mydecine Innovations Group Inc.
Mydecine Innovations Group Inc.
Listing Exchange:
CSEStatus:
DelistedIndustry:
Life SciencesSymbol:
MYCOAssociated Securities:
Mydecine Innovations Group Inc. 12FEB2024 WarrantsCSE Index:
Currency:
Mydecine Innovations Group is a life sciences company dedicated to the development and commercialization of adaptive pathway medicines, natural health products and digital health solutions.
Mydecine Innovations Group Inc. (MYCO)
SEDAR Information
Company Info
Address
789 W Pender Street, Suite 810
Vancouver, BC V6C 1H2
CanadaPhone
604-687-2038Email
contact@mydecineinc.comWebsite
http://www.mydecineinc.comListing date
Monday, August 18, 2014Transfer Agent
National Securities Administrators Ltd.Investor Relations
D. Joshua BartchEmail
contact@mydecineinc.comAuditor
MNP LLPCapitalization
Issued & Outstanding:
227,275,407Reserved for Issuance:
52,748,136News Releases
Bulletins
19/03/2021
2021-0332 - Delist - Mydecine Innovations Group Inc. (MYCO, MYCO.WT)
le 22 mars/March 2021
At the request of the company the common shares and warrants of Mydecine Innovations Group Inc. will be delisted at market close on March 22, 2021.
The Company’s common shares will continue to trade on NEO Stock Exchange.
For further information please see the issuer’s press release.
________________________________
Advertisement
Publicité
Upcoming Events
TAKESTOCK - Calgary Investor Forum
Wednesday, June 7, 2023 -9:00am to 5:00pm
Summit on Responsible Investment
Tuesday, June 27, 2023 -9:00am to 7:00pm
